Randomised controlled trial of two different dosing regimens of praziquantel anti-bilharzia drug

Not Applicable

Completed

• Conditions: rinary schistosomiasis in children; Infections and Infestations; Schistosomiasis due to Schistosoma haematobium [urinary schistosomiasis]

• Registration Number: ISRCTN18009264
• Lead Sponsor: The National Ribat University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2017-04-01
• Study Start: 2019-08-28
• Last Update Posted: 16 September 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 105

Inclusion Criteria

1. School age children (6-14 years of age)
2. Male and females
3. Positive urine test for Schistosoma ova
4. Lives in specific locality of Elkeriab and Tayba Elkababish, Khartoum State, Sudan

Exclusion Criteria

1. Refused to participate in the study
2. Age less than 6 years or more than 14 years

Study & Design

• Study Type: Interventional
• Study Design: Not specified